Trial site
Oregon Health & Science University (OHSU)
- 23running trials
- 11closed trials
The trials here
What the 34 trials at this site are about, from their registry records.
- Conditions
- Head and neck cancer3 trials
- Alzheimer disease2 trials
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Dilated cardiomyopathy2 trials
- Gastric and oesophageal cancer2 trials
- Heart failure2 trials
- High blood pressure2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Parkinson disease2 trials
- Sarcoma2 trials
- and 23 more
- Phase
- Phase 27 trials
- Phase 36 trials
- Phase 1/24 trials
- Phase 13 trials
- Early phase 12 trials
- Phase 2/32 trials
- Status
- Recruiting11 trials
- Active, not recruiting10 trials
- Completed6 trials
- Terminated4 trials
- Not yet recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- CRISPR Therapeutics AG2 trials
- Kardigan, Inc.2 trials
- Oregon Health and Science University2 trials
- Presage Biosciences2 trials
- Agenus Inc.1 trial
- and 25 more
Running trials
Recruiting
Recruiting
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
Recruiting
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Active, not recruiting
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
Active, not recruiting
Recruiting
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
Active, not recruiting
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Active, not recruiting
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
Active, not recruiting
Active, not recruiting
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Recruiting
Recruiting
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Active, not recruiting
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer2 recruiting
- Dilated cardiomyopathy2 recruiting
- Lung cancer2 recruiting
- Parkinson disease2 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Follicular lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Hodgkin lymphoma1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Completed
Completed
Completed
Millipede AspiRation for Revascularization in Stroke (MARRS) Study
Withdrawn
Completed
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Terminated
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026